Can allergy shots work as well for kids as adults? new study aims to find out.
NCT ID NCT05186025
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This 5-year study is looking at how well a year-round allergy treatment (MATA trees or MATA grass) works for children and adults with pollen allergies, including hay fever and mild asthma. Researchers want to see if the treatment is as effective in kids as it is in adults. About 320 participants aged 5 and older will track their symptoms and medication use during pollen seasons.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MATA trees or MATA grass (modified allergen extracts adsorbed to microcrystalline tyrosine)
What this could lead to
If successful, this could confirm that a shorter, year-round allergy treatment works equally well for children and adults, offering a convenient option for managing pollen allergies.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. It also does not test a new treatment, but rather compares how well an existing one works in different age groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC CONJUNCTIVITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Universitätsklinikum Augsburg
Augsburg, Germany